LBP-20-VK2809, a novel liver-directed thyroid receptor beta agonist, significantly reduces liver fat with both low and high doses in patients with non-alcoholic fatty liver disease: a phase 2 randomized, placebo-controlled trial
Too much inflammation and the repair process stalls or produces fibrous tissue instead of bone
Molecular pathways related to sulforaphane as adjuvant treatment: A nanomedicine perspective in breast cancer
Aqualyx, helping them decide which treatment better aligns with their goals
Rome III, a set of criteria used to diagnose functional GI disorders, describes the diagnosis of chronic constipation as constipation for at least six months as well as specific symptoms for at least three months (eg, straining with at least 25% of bowel movements, details here)
But behind the glowing reviews and scientific jargon lies a growing number of red flags